Current research on LECT2 is focused on cell-derived chemotaxin 2, angiogenesis, leukocyte chemotactic factor 2 amyloidosis (ALECT2), diagnosis, and biliary atresia (BA), marking an emerging period of study. This evidence concerns the gene LECT2 and breast angiosarcoma.